JP2022529502A5 - - Google Patents
Info
- Publication number
- JP2022529502A5 JP2022529502A5 JP2021562989A JP2021562989A JP2022529502A5 JP 2022529502 A5 JP2022529502 A5 JP 2022529502A5 JP 2021562989 A JP2021562989 A JP 2021562989A JP 2021562989 A JP2021562989 A JP 2021562989A JP 2022529502 A5 JP2022529502 A5 JP 2022529502A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837518P | 2019-04-23 | 2019-04-23 | |
| US62/837,518 | 2019-04-23 | ||
| US201962859699P | 2019-06-10 | 2019-06-10 | |
| US62/859,699 | 2019-06-10 | ||
| EP20305146 | 2020-02-17 | ||
| EP20305146.1 | 2020-02-17 | ||
| EP20305145 | 2020-02-17 | ||
| EP20305145.3 | 2020-02-17 | ||
| PCT/US2020/029531 WO2020219681A1 (en) | 2019-04-23 | 2020-04-23 | Anti-cd38 antibodies and formulations |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022529502A JP2022529502A (ja) | 2022-06-22 |
| JPWO2020219681A5 JPWO2020219681A5 (https=) | 2023-05-01 |
| JP2022529502A5 true JP2022529502A5 (https=) | 2023-05-01 |
| JP7602485B2 JP7602485B2 (ja) | 2024-12-18 |
Family
ID=70739160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562989A Active JP7602485B2 (ja) | 2019-04-23 | 2020-04-23 | 抗ｃｄ３８抗体および製剤 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP3958898A1 (https=) |
| JP (1) | JP7602485B2 (https=) |
| KR (1) | KR20220003562A (https=) |
| CN (2) | CN114269375A (https=) |
| AU (1) | AU2020261039A1 (https=) |
| BR (1) | BR112021021060A2 (https=) |
| CA (1) | CA3137365A1 (https=) |
| CO (1) | CO2021015462A2 (https=) |
| IL (1) | IL287477A (https=) |
| MA (1) | MA55761A (https=) |
| MX (1) | MX2021012967A (https=) |
| MY (1) | MY206426A (https=) |
| SG (1) | SG11202111602YA (https=) |
| TW (1) | TWI878289B (https=) |
| WO (1) | WO2020219681A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023109928A1 (zh) * | 2021-12-16 | 2023-06-22 | 上海宝济药业有限公司 | 抗免疫球蛋白降解酶酶切的Fc变体 |
| WO2024023843A1 (en) * | 2022-07-26 | 2024-02-01 | Dr. Reddy’S Laboratories Limited | A pharmaceutical formulation of a therapeuticantibody and preparations thereof |
| WO2025245526A1 (en) * | 2024-05-24 | 2025-11-27 | Research Institute At Nationwide Children's Hospital | Cd-38 protein binding compositions and methods related thereto |
| CN120535629B (zh) * | 2025-04-22 | 2026-01-23 | 西安市中心血站（陕西省血液中心） | 一种用于抑制cd38单抗对输血相容性检测干扰的抗体 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005016683D1 (de) | 2004-07-10 | 2009-10-29 | Fox Chase Cancer Ct | Genetisch modifizierte, menschliche, natürliche killerzellenlinien: |
| CN103172731A (zh) * | 2004-07-15 | 2013-06-26 | 赞科股份有限公司 | 优化的Fc变体 |
| EP1914242A1 (en) * | 2006-10-19 | 2008-04-23 | Sanofi-Aventis | Novel anti-CD38 antibodies for the treatment of cancer |
| SG10201603411WA (en) * | 2011-10-28 | 2016-07-28 | Teva Pharmaceuticals Australia Pty Ltd | Polypeptide constructs and uses thereof |
| US10617757B2 (en) * | 2014-08-08 | 2020-04-14 | The Regents Of The University Of California | Methods for treating multiple myeloma |
| DK3827845T3 (da) * | 2015-11-03 | 2022-05-23 | Janssen Biotech Inc | Subkutane formuleringer af anti-cd38-antistoffer og anvendelser deraf |
| GEP20217249B (en) * | 2016-06-30 | 2021-04-26 | Inc Celltrion | Stable liquid pharmaceutical preparation |
| SG11201910134SA (en) * | 2017-05-02 | 2019-11-28 | Merck Sharp & Dohme | Stable formulations of anti-ctla4 antibodies alone and in combination with programmed death receptor 1 (pd-1) antibodies and methods of use thereof |
| WO2019064263A1 (en) * | 2017-09-29 | 2019-04-04 | Janssen Biotech, Inc. | NOVEL FORMULATIONS FOR STABILIZING LOW DOSE ANTIBODY COMPOSITIONS |
| CN108752475B (zh) * | 2018-06-14 | 2021-07-30 | 北京智仁美博生物科技有限公司 | 抗人cd38抗体及其用途 |
-
2020
- 2020-04-23 TW TW109113639A patent/TWI878289B/zh active
- 2020-04-23 MY MYPI2021006312A patent/MY206426A/en unknown
- 2020-04-23 MX MX2021012967A patent/MX2021012967A/es unknown
- 2020-04-23 CA CA3137365A patent/CA3137365A1/en active Pending
- 2020-04-23 MA MA055761A patent/MA55761A/fr unknown
- 2020-04-23 WO PCT/US2020/029531 patent/WO2020219681A1/en not_active Ceased
- 2020-04-23 SG SG11202111602YA patent/SG11202111602YA/en unknown
- 2020-04-23 CN CN202080030148.3A patent/CN114269375A/zh active Pending
- 2020-04-23 EP EP20726267.6A patent/EP3958898A1/en active Pending
- 2020-04-23 JP JP2021562989A patent/JP7602485B2/ja active Active
- 2020-04-23 BR BR112021021060A patent/BR112021021060A2/pt unknown
- 2020-04-23 KR KR1020217037641A patent/KR20220003562A/ko not_active Ceased
- 2020-04-23 CN CN202510964194.5A patent/CN120757645A/zh active Pending
- 2020-04-23 AU AU2020261039A patent/AU2020261039A1/en active Pending
-
2021
- 2021-10-21 IL IL287477A patent/IL287477A/en unknown
- 2021-11-17 CO CONC2021/0015462A patent/CO2021015462A2/es unknown